Status:
UNKNOWN
Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
Lead Sponsor:
Hospital Arnau de Vilanova
Collaborating Sponsors:
Pfizer
Conditions:
Atherosclerosis
Cardiovascular Diseases
Eligibility:
All Genders
40-74 years
Phase:
PHASE4
Brief Summary
The incidence of cardiovascular diseases is still high and further efforts should be done in primary prevention. The main objective is to quantify the burden of subclinical atherosclerosis using non-i...
Detailed Description
We will perform non-invasive techniques (carotid Intima-Media Thickness, CAC score and ankle-brachial index) to individuals at intermediate cardiovascular risk.With these results, we will classify par...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- One or more of the following:
- Familiar History of early-onset cardiovascular disease (male \< 55 or female \< 65).
- Type 2 Diabetes mellitus or type 1 with microalbuminuria.
- Essential High Blood Pressure.
- Chronic Kidney Disease.
- Primary hyperlipidemia.
- The presence of two or more of the following:
- Current smoker.
- Physical inactivity.
- High blood pressure (recently diagnosed).
- Abdominal perimeter: \> 102 cm. males; \> 88 cm. females.
- Total cholesterol \> 240 mg/dL.
- HDL cholesterol ≤ 40 mg/dL males, ≤ 50 mg/dL females.
- Exclusion Criteria:
- Age \< 40 or \> 74 years old.
- Previous Cardiovascular Event.
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2013
Estimated Enrollment :
2948 Patients enrolled
Trial Details
Trial ID
NCT00734123
Start Date
April 1 2008
End Date
May 1 2013
Last Update
August 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Arnau de Vilanova
Lleida, Catalonia, Spain, 25260